Evaluate ANNX stock safety — financial health, volatility, institutional backing, and risk factors.

What are the risks of investing in ANNX? | Glauxie AI

Q: What are the risks of investing in ANNX?

Annexon, Inc. (ANNX) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Douglas E. Love. Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule... Employees: 96.

Q: How much debt does ANNX have?

Review ANNX total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Q: Is ANNX a good long-term investment?

Evaluate ANNX as a long-term investment using fundamental scores, growth metrics, and risk assessment.

What are the risks of investing in ANNX?

🦉

Annexon, Inc. (ANNX)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEODouglas E. Love

Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as...

Key Executives

Name	Title
Dean R. Artis	Chief Scientific Officer & Executive Vice President
Douglas Love	Chief Executive Officer, President & Director
Henk-Andre Kroon	Senior Vice President of Translational Medicine
Jamie Dananberg	Executive Vice President & Chief Medical Officer
Jennifer Lew	Executive Vice President, Chief Financial Officer & Corporate Secretary
Lloyd Clark	Senior Vice President of Ophthalmology Strategy & Innovation

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

ANNX Profile Financials

Is ANNX stock safe? How much debt does ANNX have? Is ANNX a good long-term investment?